ID   ZN322_HUMAN             Reviewed;         402 AA.
AC   Q6U7Q0; A8K1X3; Q0VDH6; Q6B0G2; Q86W72; Q9H5I9;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 2.
DT   28-JUN-2023, entry version 155.
DE   RecName: Full=Zinc finger protein 322;
DE   AltName: Full=Zinc finger protein 322A;
DE   AltName: Full=Zinc finger protein 388;
DE   AltName: Full=Zinc finger protein 489;
GN   Name=ZNF322; Synonyms=ZNF322A, ZNF388, ZNF489;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN TRANSCRIPTIONAL ACTIVATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryonic heart;
RX   PubMed=15555580; DOI=10.1016/j.bbrc.2004.10.183;
RA   Li Y., Wang Y., Zhang C., Yuan W., Wang J., Zhu C., Chen L., Huang W.,
RA   Zeng W., Wu X., Liu M.;
RT   "ZNF322, a novel human C(2)H(2) Kruppel-like zinc-finger protein, regulates
RT   transcriptional activation in MAPK signaling pathways.";
RL   Biochem. Biophys. Res. Commun. 325:1383-1392(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hepatoma, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Transcriptional activator (PubMed:15555580). Important for
CC       maintenance of pluripotency in embryonic stem cells (By similarity).
CC       Binds directly to the POU5F1 distal enhancer and the NANOG proximal
CC       promoter, and enhances expression of both genes (By similarity). Can
CC       also bind to numerous other gene promoters and regulates expression of
CC       many other pluripotency factors, either directly or indirectly (By
CC       similarity). Promotes inhibition of MAPK signaling during embryonic
CC       stem cell differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BZ89, ECO:0000269|PubMed:15555580}.
CC   -!- SUBUNIT: Interacts with POU5F1. {ECO:0000250|UniProtKB:Q8BZ89}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15555580}. Nucleus
CC       {ECO:0000269|PubMed:15555580}. Note=Mainly found in the nucleus.
CC       {ECO:0000269|PubMed:15555580}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart and skeletal
CC       muscle. {ECO:0000269|PubMed:15555580}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryo as early as the 11th week of
CC       gestation. {ECO:0000269|PubMed:15555580}.
CC   -!- MISCELLANEOUS: Significantly enhances POU5F1/OCT4-SOX2-KLF4-MYC (OSKM)
CC       mediated reprogramming of mouse embryonic fibroblasts into induced
CC       pluripotent stem cells, and can also substitute for SOX2 in this
CC       process. {ECO:0000250|UniProtKB:Q8BZ89}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15637.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY376736; AAQ85127.1; -; mRNA.
DR   EMBL; AK027046; BAB15637.1; ALT_INIT; mRNA.
DR   EMBL; AK290038; BAF82727.1; -; mRNA.
DR   EMBL; BC050425; AAH50425.2; -; mRNA.
DR   EMBL; BC074772; AAH74772.1; -; mRNA.
DR   EMBL; BC119669; AAI19670.1; -; mRNA.
DR   CCDS; CCDS4617.1; -.
DR   RefSeq; NP_001229726.1; NM_001242797.1.
DR   RefSeq; NP_001229727.1; NM_001242798.1.
DR   RefSeq; NP_001229728.1; NM_001242799.1.
DR   RefSeq; NP_078915.2; NM_024639.4.
DR   AlphaFoldDB; Q6U7Q0; -.
DR   SMR; Q6U7Q0; -.
DR   BioGRID; 122813; 3.
DR   STRING; 9606.ENSP00000482607; -.
DR   GlyCosmos; Q6U7Q0; 2 sites, 1 glycan.
DR   GlyGen; Q6U7Q0; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q6U7Q0; -.
DR   PhosphoSitePlus; Q6U7Q0; -.
DR   BioMuta; ZNF322; -.
DR   DMDM; 82582384; -.
DR   jPOST; Q6U7Q0; -.
DR   MassIVE; Q6U7Q0; -.
DR   MaxQB; Q6U7Q0; -.
DR   PaxDb; Q6U7Q0; -.
DR   PeptideAtlas; Q6U7Q0; -.
DR   ProteomicsDB; 67397; -.
DR   Antibodypedia; 11103; 130 antibodies from 19 providers.
DR   DNASU; 79692; -.
DR   Ensembl; ENST00000415922.7; ENSP00000418897.1; ENSG00000181315.11.
DR   Ensembl; ENST00000456172.5; ENSP00000478899.1; ENSG00000181315.11.
DR   Ensembl; ENST00000471278.5; ENSP00000419728.1; ENSG00000181315.11.
DR   Ensembl; ENST00000607204.5; ENSP00000483223.1; ENSG00000181315.11.
DR   Ensembl; ENST00000622479.4; ENSP00000482607.1; ENSG00000181315.11.
DR   GeneID; 79692; -.
DR   KEGG; hsa:79692; -.
DR   MANE-Select; ENST00000415922.7; ENSP00000418897.1; NM_024639.5; NP_078915.2.
DR   UCSC; uc003nil.4; human.
DR   AGR; HGNC:23640; -.
DR   CTD; 79692; -.
DR   DisGeNET; 79692; -.
DR   GeneCards; ZNF322; -.
DR   HGNC; HGNC:23640; ZNF322.
DR   HPA; ENSG00000181315; Low tissue specificity.
DR   MIM; 610847; gene.
DR   neXtProt; NX_Q6U7Q0; -.
DR   OpenTargets; ENSG00000181315; -.
DR   PharmGKB; PA134861342; -.
DR   VEuPathDB; HostDB:ENSG00000181315; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162956; -.
DR   HOGENOM; CLU_002678_44_10_1; -.
DR   InParanoid; Q6U7Q0; -.
DR   OMA; CNMGEKG; -.
DR   OrthoDB; 2882612at2759; -.
DR   PhylomeDB; Q6U7Q0; -.
DR   TreeFam; TF338126; -.
DR   PathwayCommons; Q6U7Q0; -.
DR   SIGNOR; Q6U7Q0; -.
DR   BioGRID-ORCS; 79692; 15 hits in 1136 CRISPR screens.
DR   ChiTaRS; ZNF322; human.
DR   GenomeRNAi; 79692; -.
DR   Pharos; Q6U7Q0; Tbio.
DR   PRO; PR:Q6U7Q0; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q6U7Q0; protein.
DR   Bgee; ENSG00000181315; Expressed in cerebellar vermis and 108 other tissues.
DR   ExpressionAtlas; Q6U7Q0; baseline and differential.
DR   Genevisible; Q6U7Q0; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 11.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24399; ZINC FINGER AND BTB DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR24399:SF9; ZINC FINGER PROTEIN 572; 1.
DR   Pfam; PF00096; zf-C2H2; 7.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 7.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   Activator; Cytoplasm; DNA-binding; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..402
FT                   /note="Zinc finger protein 322"
FT                   /id="PRO_0000047529"
FT   ZN_FING         43..65
FT                   /note="C2H2-type 1; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         71..93
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         99..121
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         127..149
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         155..177
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         183..205
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         211..233
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         239..261
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         267..289
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         293..315
FT                   /note="C2H2-type 10; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         351..373
FT                   /note="C2H2-type 11; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   MOD_RES         391
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CONFLICT        33
FT                   /note="H -> R (in Ref. 1; AAQ85127)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        73
FT                   /note="C -> S (in Ref. 2; BAB15637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94
FT                   /note="N -> H (in Ref. 1; AAQ85127)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="C -> R (in Ref. 1; AAQ85127)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="H -> R (in Ref. 1; AAQ85127)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        398
FT                   /note="A -> V (in Ref. 1; AAQ85127)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   402 AA;  46941 MW;  A9A54EC8884BD27D CRC64;
     MYTSEEKCNQ RTQKRKIYNV CPRKGKKIFI HMHEIIQIDG HIYQCLECKQ NFCENLALIM
     CERTHTGEKP YKCDMCEKTF VQSSDLTSHQ RIHNYEKPYK CSKCEKSFWH HLALSGHQRT
     HAGKKFYTCD ICGKNFGQSS DLLVHQRSHT GEKPYLCSEC DKCFSRSTNL IRHRRTHTGE
     KPFKCLECEK AFSGKSDLIS HQRTHTGERP YKCNKCEKSY RHRSAFIVHK RVHTGEKPYK
     CGACEKCFGQ KSDLIVHQRV HTGEKPYKCL ECMRSFTRSA NLIRHQATHT HTFKCLEYEK
     SFNCSSDLIV HQRIHMEEKP HQWSACESGF LLGMDFVAQQ KMRTQTEELH YKYTVCDKSF
     HQSSALLQHQ TVHIGEKPFV CNVSEKGLEL SPPHASEASQ MS
//
